Tag: Pharmaceuticals
Business & Industry
Chemspec Europe 2026 Draws Global Industry Participation
Chemspec Europe returned to Cologne on 6–7 May 2026, bringing together professionals from across the speciality chemicals sector despite ongoing economic and regulatory challenges...
Business & Industry
Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy
After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than...
Business & Industry
Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems
Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy its Claude platform across global operations. This initiative moves beyond standard...
Business & Industry
Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition
Angelini Pharma has finalized a definitive agreement to acquire Catalyst Pharmaceuticals for an equity value of approximately €3.5bn ($4.1bn). This move marks a strategic...
Business & Industry
UCB Acquires Candid Therapeutics in a $2 Billion-Plus Deal to Strengthen Immunology Pipeline
Belgian pharmaceutical company UCB is making a substantial move to expand its immunology pipeline, entering into a multi-billion dollar agreement to acquire Candid Therapeutics...
Business & Industry
Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal
Teva Pharmaceuticals has entered into a definitive agreement to acquire Emalex Biosciences, strengthening its neuroscience pipeline through the addition of ecopipam, a late-stage investigational...
Business & Industry
Lilly Acquires CrossBridge to Expand Next-Gen ADC Pipeline
Eli Lilly and Company has entered into an agreement to acquire all outstanding shares of CrossBridge Bio in a transaction valued at up to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read